EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Effects of Chromium Picolinate Supplementation on Cardiometabolic Biomarkers in Patients with Type 2 Diabetes Mellitus: a Randomized Clinical Trial

Aria Tavakoli Talab iD, Hadi Abdollahzad iD, Seyyed Mustafa Nachvak iD, Yahya Pasdar iD, Shahryar Eghtesadi iD, Azimeh Izadi iD, Mir Amir Aghdashi iD, Mohammad Reza Mohammad Hossseini Azar iD, Sedighe Moradi iD, Behzad Mehaki iD, Shima Moradi iD

Clinical Nutrition Research · 2020 · 9 (2) · 97

DOI: 10.7762/cnr.2020.9.2.97 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical Nutrition Research, 2020. Verfasst von Aria Tavakoli Talab und 10 weiteren Autor:innen. Beteiligte Einrichtung: Be'sat Hospital, Hamadan University of Medical Sciences, Hamadan 6517838678, Iran. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) is a serious public health problem accompanies with several complications. This study was conducted to evaluate the effects of chromium picolinate (CrPic) supplementation on the glycemic status and lipid profile in patients with T2DM. The patients with T2DM (n = 52) were randomly allocated into 2 groups. One group received 400 µg CrPic per day and the other group took placebo; the intervention duration was 8 weeks. Anthropometric indices and metabolic factors were measured at the beginning, and at end of the study. The patients were recommended not to change their normal diet, life style and medication. No significant changes were observed for weight, body mass index, and fasting blood glucose (FBG) in both groups; while intra-groups changes in homeostatic model assessment for insulin resistance (HOMA-IR) value was significant (p < 0.05). Results of analysis of covariance showed that there were significance differences between groups in total cholesterol, low density lipoprotein cholesterol and HOMA-IR at the end of the intervention adjusting for baseline levels (p = 0.035, 0.030 and < 0.001, respectively). In this study, oral supplementation with 400 µg CrPic for eight weeks did not alter FBG concentration as well as anthropometric parameters in individuals with T2DM. However, the modest beneficial effects of chromium supplementation on insulin resistance as indicated by HOMA-IR and lipid profile were found.

Schlagwörter

Stichwörter der Autor:innen

Blood glucoseChromiumDyslipidemiaType 2 diabetes mellitus

Autor:innen und Institutionen

  • Be'sat Hospital, Hamadan University of Medical Sciences, Hamadan 6517838678, Iran.
  • Department of Nutrition, Research Center for Environmental Determinants of Health, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6719851351, Iran.
  • Islamic Azad University; Tehran Medical Branch and Science & Research Branch, Tehran 1477983855, Iran.
  • Students' Research Committee, Faculty of Nutrition, Tabriz University of Medical Sciences, Tabriz 5166614711, Iran.
  • Department of Internal Medicine, Faculty of Medicine, Urmia University of Medical Sciences, Urmia 5714783734, Iran.
  • Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran 1593716615, Iran.

ORCID-Profile: Aria Tavakoli Talab, Hadi Abdollahzad, Seyyed Mustafa Nachvak, Yahya Pasdar, Shahryar Eghtesadi, Azimeh Izadi, Mir Amir Aghdashi, Mohammad Reza Mohammad Hossseini Azar, Sedighe Moradi, Behzad Mehaki, Shima Moradi

Zitieren

APA

Talab, A. T., Abdollahzad, H., Nachvak, S. M., Pasdar, Y., Eghtesadi, S., Izadi, A., Aghdashi, M. A., Mohammad Hossseini Azar, M. R., Moradi, S., Mehaki, B., & Moradi, S. (2020). Effects of Chromium Picolinate Supplementation on Cardiometabolic Biomarkers in Patients with Type 2 Diabetes Mellitus: a Randomized Clinical Trial. Clinical Nutrition Research, 9(2), 97. https://doi.org/10.7762/cnr.2020.9.2.97

Vancouver

Talab AT, Abdollahzad H, Nachvak SM, Pasdar Y, Eghtesadi S, Izadi A, et al. Effects of Chromium Picolinate Supplementation on Cardiometabolic Biomarkers in Patients with Type 2 Diabetes Mellitus: a Randomized Clinical Trial. Clinical Nutrition Research. 2020;9(2):97. doi:10.7762/cnr.2020.9.2.97

BibTeX
@article{Talab2020,
  author = {Talab, Aria Tavakoli and Abdollahzad, Hadi and Nachvak, Seyyed Mustafa and Pasdar, Yahya and Eghtesadi, Shahryar and Izadi, Azimeh and Aghdashi, Mir Amir and Mohammad Hossseini Azar, Mohammad Reza and Moradi, Sedighe and Mehaki, Behzad and Moradi, Shima},
  title = {Effects of Chromium Picolinate Supplementation on Cardiometabolic Biomarkers in Patients with Type 2 Diabetes Mellitus: a Randomized Clinical Trial},
  journal = {Clinical Nutrition Research},
  year = {2020},
  volume = {9},
  number = {2},
  pages = {97},
  doi = {10.7762/cnr.2020.9.2.97}
}
Kostenlos starten →